Novo Nordisk A/S Class B NOVO_B
OMXCOP · Denmark · Health Technology
DKK 248.60-4.60 (-1.82%)
Market open· · DKK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · DKK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 6.18 | 5.03 | +22.9% | DKK 78.49B | +10.0% | -2.6%DKK 302.30→DKK 294.30 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.